395 related articles for article (PubMed ID: 22301210)
1. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease.
Siracuse JJ; Giles KA; Pomposelli FB; Hamdan AD; Wyers MC; Chaikof EL; Nedeau AE; Schermerhorn ML
J Vasc Surg; 2012 Apr; 55(4):1001-7. PubMed ID: 22301210
[TBL] [Abstract][Full Text] [Related]
2. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
[TBL] [Abstract][Full Text] [Related]
3. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
[TBL] [Abstract][Full Text] [Related]
4. The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease--decision analysis.
Nolan B; Finlayson S; Tosteson A; Powell R; Cronenwett J
J Vasc Surg; 2007 Jun; 45(6):1179-84. PubMed ID: 17543682
[TBL] [Abstract][Full Text] [Related]
5. Endovascular treatment of lesions in the below-knee popliteal artery.
Siracuse JJ; Gill HL; Cassidy SP; Messina MD; Catz D; Egorova N; Parrack I; McKinsey JF
J Vasc Surg; 2014 Aug; 60(2):356-61. PubMed ID: 24650745
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of interventions for recurrent disease after endoluminal intervention for superficial femoral artery disease.
Davies MG; Bismuth J; Saad WE; Naoum JJ; Peden EK; Lumsden AB
J Vasc Surg; 2010 Aug; 52(2):331-9.e1-2. PubMed ID: 20478687
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcome of Drug-Eluted Stenting (Zilver PTX) in Patients With Femoropopliteal Occlusive Disease a Single Center Experience.
AbuRahma AF; Beasley M; AbuRahma ZT; Davis M; Adams E; Dean LS; Shapiro J; Scott G; Davis E
J Endovasc Ther; 2022 Jun; 29(3):350-360. PubMed ID: 34622706
[TBL] [Abstract][Full Text] [Related]
9. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
10. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs.
Giles KA; Pomposelli FB; Spence TL; Hamdan AD; Blattman SB; Panossian H; Schermerhorn ML
J Vasc Surg; 2008 Jul; 48(1):128-36. PubMed ID: 18502084
[TBL] [Abstract][Full Text] [Related]
11. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
12. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
13. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of drug-coated balloon angioplasty in patients with femoropopliteal disease: A real-world single-center experience.
AbuRahma AF; AbuRahma ZT; Scott G; Adams E; Beasley M; Davis M; Dean LS; Davis E
J Vasc Surg; 2019 Dec; 70(6):1950-1959. PubMed ID: 31401115
[TBL] [Abstract][Full Text] [Related]
15. Isolated femoral endarterectomy: impact of SFA TASC classification on recurrence of symptoms and need for additional intervention.
Al-Khoury G; Marone L; Chaer R; Rhee R; Cho J; Leers S; Makaroun M; Gupta N
J Vasc Surg; 2009 Oct; 50(4):784-9. PubMed ID: 19628359
[TBL] [Abstract][Full Text] [Related]
16. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease.
Conrad MF; Kang J; Cambria RP; Brewster DC; Watkins MT; Kwolek CJ; LaMuraglia GM
J Vasc Surg; 2009 Oct; 50(4):799-805.e4. PubMed ID: 19786239
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous angioplasty and stenting of the superficial femoral artery.
Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of subintimal angioplasty for limb salvage in lower extremities with severe chronic ischemia and limb-threatening ischemia.
Myers SI; Myers DJ; Ahmend A; Ramakrishnan V
J Vasc Surg; 2006 Dec; 44(6):1239-46. PubMed ID: 17145425
[TBL] [Abstract][Full Text] [Related]
19. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
20. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
